This study provides a brief overview of commonly used machine learning approaches, as well as challenges in further application of machine learning techniques in epilepsy.
These researchers assess three different seizure outcome measures (relative seizure reduction, absolute seizure reduction, and seizure freedom [yes/no]) to investigate which measure best predicts postoperative quality of life.
The midazolam administered as a single-dose nasal spray was superior to placebo in providing rapid, sustained seizure control when administered to patients experiencing an seizure clusters in the outpatient setting and was associated with a favorable safety profile.
CBD
MGC Pharmaceuticals has received Human Research Ethics Committee approval to conduct a head-to-head clinical study to compare the effectiveness of its low THC formula for the treatment of drug-resistant epilepsy to its 100% CBD product.
Study finds that public health campaigns targeting inactivity are warranted.
Researcher Lim Hyun-Ho discovered a new 3-D structure and membrane protein mechanism which causes epilepsy and muscle problems.
This article summarizes methodological changes in antiepileptic drug trials and associated advances in knowledge starting from 1938, the year phenytoin was introduced and also the year when evidence of safety was made a requirement for the marketing of medicines in the United States.
Seizures and their consequences affect every aspect of a caregiver’s world: their physical health, emotional health, psychological health, social relationships, education, employment, finances and futures.
A $530,000 grant from the Canadian Institutes of Health Research (CIHR) will allow a University of Lethbridge neuroscientist to investigate whether seizures can be triggered by memory.
